MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential. Issue 1 (1st December 2015)

• Record Type: Journal Article
• Authors: Chiang, Kun-Chun; Kuo, Sheng-Fong; Chen, Chih-Hung; Ng, Sohching; Lin, Shu-Fu; Yeh, Chun-Nan; Chen, Li-Wei; Takano, Masashi; Chen, Tai C.; Juang, Horng-Heng; Kittaka, Atsushi; Lin, Jen-Der; Pang, Jong-Hwei S.
• Is Part Of: Cancer letters. Volume 369:Issue 1(2016)
• Page Start: 76
• Page End: 85
• Publication Date: 2015-12-01
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Electronic journals; 616.994
• DOI: 10.1016/j.canlet.2015.07.024
• Languages: English
• ISSNs: 0304-3835

Abstract

<abstract abstract-type="author-highlights" id="ab0010"> <title id="st0010">Highlights</title> <sec> <p id="sp0010"> <list id="ulist0010"> <list-item id="u0010"> <label></label> <p id="p0010">Anaplastic thyroid cancer is a very aggressive disease without effective treatment available.</p> </list-item> <list-item id="u0015"> <label></label> <p id="p0015">MART-10 MART-10 has been shown to be more pottent than 1α, 25(OH)₂D₃ in inhibitin a variety of cancers growth.</p> </list-item> <list-item id="u0020"> <label></label> <p id="p0020">MART-10 and 1α, 25(OH)₂D₃ both are effitve drug to inhibt anaplastic thyroid cancer metasasis with MART-10 much more poten, encouraging further in vivo studies.</p> </list-item> </list> </p> </sec> </abstract>